Biocompatibility assessment of the centrimag-novalung adult ECMO circuit in a model of acute pulmonary hypertension

ASAIO Journal

Volumn 60, Issue 4, 2014, Pages 429-435

  Shankarraman, Venkat ^a,b   Kocyildirim, Ergin ^a,b   Olia, Salim E ^b,c   Kameneva, Marina V ^b,c   Dzadony, Ryan J ^d   Maul, Timothy M ^b   Simon, Marc A ^a   Champion, Hunter C ^a   Wagner, William R ^a,b,c   Bermudez, Christian A ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^c University of Pittsburgh   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Biocompatibility; ECMO; Platelet activation; Pulmonary hypertension

Indexed keywords

BIOCOMPATIBILITY; CARBON DIOXIDE; CHEMICAL ACTIVATION; HEMOGLOBIN; PHOSPHOLIPIDS; PROTEINS; RESPIRATORY THERAPY;

ECMO; EXTRACORPOREAL MEMBRANE OXYGENATION; FIBRINOGEN CONCENTRATION; LUNG TRANSPLANTATION; PLATELET ACTIVATION; PLATELET-ACTIVATING FACTORS; PULMONARY HYPERTENSION; TRANSMEMBRANE PRESSURES;

PLATELETS;

ACUTE DISEASE; ANIMAL; DISEASE MODEL; EXTRACORPOREAL OXYGENATION; HYPERTENSION, PULMONARY; MATERIALS TESTING; PHYSIOLOGY; SHEEP; THROMBOCYTE ACTIVATION; THROMBOELASTOGRAPHY;

ACUTE DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; EXTRACORPOREAL MEMBRANE OXYGENATION; HYPERTENSION, PULMONARY; MATERIALS TESTING; PLATELET ACTIVATION; SHEEP; THROMBELASTOGRAPHY;

EID: 84905862051     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000079     Document Type: Article

References (35)

1. Jackson A, Cropper J, Pye R, Junius F, Malouf M, Glanville A: Use of extracorporeal membrane oxygenation as a bridge to primary lung transplant: 3 consecutive, successful cases and a review of the literature. J Heart Lung Transplant 27: 348-352, 2008
2. Bermudez CA, Adusumilli PS, McCurry KR, et al: Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: Long-term survival. Ann Thorac Surg 87: 854-860, 2009
3. Wiklund L, Haraldsson A, Selimovic N, Kjellman U: Extracorporeal membrane oxygenation as a bridge to lung transplantation in a patient with persistent severe porto-pulmonary arterial hypertension following liver transplantation. Eur J Cardiothorac Surg 39: 777-778, 2011
4. Kramer MR: [Combination treatment in pulmonary arterial hypertension]. Harefuah 150: 383-388, 417, 2011
5. Poms A, Kingman M: Inhaled treprostinil for the treatment of pulmonary arterial hypertension. Crit Care Nurse 31: e1-e10, 2011
6. Lordan JL, Corris PA: Pulmonary arterial hypertension and lung transplantation. Expert Rev Respir Med 5: 441-454, 2011
7. Stayer SA, Liu Y: Pulmonary hypertension of the newborn. Best Pract Res Clin Anaesthesiol 24: 375-386, 2010
8. Oliver WC: Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth 13: 154-175, 2009
9. Zavadil DP, Stammers AH, Willett LD, Deptula JJ, Christensen KA, Sydzyik RT: Hematological abnormalities in neonatal patients treated with extracorporeal membrane oxygenation (ECMO). J Extra Corpor Technol 30: 83-90, 1998
10. Fortenberry JD, Bhardwaj V, Niemer P, Cornish JD, Wright JA, Bland L: Neutrophil and cytokine activation with neonatal extracorporeal membrane oxygenation. J Pediatr 128(5 pt 1): 670-678, 1996
11. Kopp R, Mottaghy K, Kirschfink M: Mechanism of complement activation during extracorporeal blood-biomaterial interaction: Effects of heparin coated and uncoated surfaces. ASAIO J 48: 598-605, 2002
12. Dasse KA, Gellman B, Kameneva MV, et al: Assessment of hydraulic performance and biocompatibility of a MagLev centrifugal pump system designed for pediatric cardiac or cardiopulmonary support. ASAIO J 53: 771-777, 2007
13. Sanchez-Lorente D, Go T, Jungebluth P, et al: Single double-lumen venous-venous pump-driven extracorporeal lung membrane support. J Thorac Cardiovasc Surg 140: 558-563, 563.e1, 2010
14. Fujiwara T, Nagaoka E, Watanabe T, et al: New generation extracorporeal membrane oxygenation with MedTech Mag-Lev, a singleuse, magnetically levitated, centrifugal blood pump: Preclinical evaluation in calves. Artif Organs 37: 447-456, 2013
15. Naeije R, Dewachter L: [Animal models of pulmonary arterial hypertension]. Rev Mal Respir 24(4 pt 1): 481-496, 2007
16. Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF: Animal models of pulmonary arterial hypertension: The hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol 297: L1013-L1032, 2009
17. Johnson CA Jr., Vandenberghe S, Daly AR, et al: Biocompatibility assessment of the first generation PediaFlow pediatric ventricular assist device. Artif Organs 35:9-21, 2011
18. Johnson CA Jr., Wearden PD, Kocyildirim E, et al: Platelet activation in ovines undergoing sham surgery or implant of the second generation PediaFlow pediatric ventricular assist device. Artif Organs 35: 602-613, 2011
19. Johnson CA Jr., Snyder TA, Woolley JR, Wagner WR: Flow cytometric assays for quantifying activated ovine platelets. Artif Organs 32: 136-145, 2008
20. Chen A, Teruya J: Global hemostasis testing thromboelastography: Old technology, new applications. Clin Lab Med 29: 391-407, 2009
21. Cypel M, Keshavjee S: Extracorporeal life support as a bridge to lung transplantation. Clin Chest Med 32: 245-251, 2011
22. Berman M, Tsui S, Vuylsteke A, Klein A, Jenkins DP: Life- threatening right ventricular failure in pulmonary hypertension: RVAD or ECMO? J Heart Lung Transplant 27: 1188-1189, 2008
23. Fischer S, Hoeper MM, Tomaszek S, et al: Bridge to lung transplantation with the extracorporeal membrane ventilator Novalung in the veno-venous mode: The initial Hannover experience. ASAIO J 53: 168-170, 2007
24. Borchardt R, Schlanstein P, Arens J, et al: Description of a flow optimized oxygenator with integrated pulsatile pump. Artif Organs 34: 904-910, 2010
25. Borchardt R, Schlanstein P, Mager I, Arens J, Schmitz-Rode T, Steinseifer U: In vitro performance testing of a pediatric oxygenator with an integrated pulsatile pump. ASAIO J 58: 420-425, 2012
26. Brancaccio G, Amodeo A, Ricci Z, et al: Mechanical assist device as a bridge to heart transplantation in children less than 10 kilograms. Ann Thorac Surg 90: 58-62, 2010
27. Costello JM, Cooper DS, Jacobs JP, et al: Intermediate-term outcomes after paediatric cardiac extracorporeal membrane oxygenation-What is known (and unknown). Cardiol Young 21(suppl 2): 118-123, 2011
28. Snyder TA, Tsukui H, Kihara S, et al: Preclinical biocompatibility assessment of the EVAHEART ventricular assist device: Coating comparison and platelet activation. J Biomed Mater Res A 81: 85-92, 2007
29. Nielsen VG, Kirklin JK, Holman WL, et al: Mechanical circulatory device thrombosis: A new paradigm linking hypercoagulation and hypofibrinolysis. ASAIO J 54: 351-358, 2008
30. Major TC, Brant DO, Reynolds MM, et al: The attenuation of platelet and monocyte activation in a rabbit model of extracorporeal circulation by a nitric oxide releasing polymer. Biomaterials 31: 2736-2745, 2010
31. Kéreveur A, Callebert J, Humbert M, et al: High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy. Arterioscler Thromb Vasc Biol 20: 2233-2239, 2000
32. Zanjani KS: Platelets in pulmonary hypertension: A causative role or a simple association? Iran J Pediatr 22: 145-157, 2012
33. Kopp R, Bensberg R, Henzler D, et al: Hemocompatibility of a miniaturized extracorporeal membrane oxygenation and a pumpless interventional lung assist in experimental lung injury. Artif Organs 34: 13-21, 2010
34. Kawahito S, Maeda T, Motomura T, et al: Hemolytic characteristics of oxygenators during clinical extracorporeal membrane oxygenation. ASAIO J 48: 636-639, 2002
35. Snyder TA, Watach MJ, Litwak KN, Wagner WR: Platelet activation, aggregation, and life span in calves implanted with axial flow ventricular assist devices. Ann Thorac Surg 73: 1933-1938, 2002.